The golden age of science is just rhetoric

Intro: Beyond the Hype

It is to support research that advances the health and longevity of American people. – Director Bhattacharya ¹ 1 00:07:44

We’re told science is at a precipice, attacked by political forces. Fine. But defending the “system before” is a trap. That system was, frankly, never a golden age. We’ve long cultivated a scientific enterprise riddled with perverse incentives, misplaced priorities, and systemic inefficiencies. The current attacks are a stress test, brutally exposing these cracks. This isn’t just a threat; it’s a chance to dismantle the broken bits and build something robust. The recent Huberman Lab podcast with new NIH Director Jay Bhattacharya ² 2 Confirmed March 25, 2025, took office April 1, 2025. lays out his vision for reform. Some goals are laudable—basic science, ECR support, reproducibility. Yet, this vision often lacks data-backed plans and clashes hard with the administration’s proposed austerity—drastic budget cuts, IDC caps, workforce reductions. ³ 3 Director Bhattacharya’s first three months saw $12 billion in grant cancellations and a staff rebellion, indicative of the upheaval. This piece is my thinking out loud on his proposals, stacking them against reality.

Foundations: Basic Science on a Diet?

“Basic science meaning fundamental biological facts that can be used in many, many, many drug studies, other research where you don’t necessarily know specifically in advance when you’re doing it what the applications are going to be.” – Director Bhattacharya ⁴ 4 00:10:36

Director Bhattacharya’s commitment to basic science—“I don’t have any intention of gutting basic science” ⁵ 5 00:16:52 —is table stakes. Everyone agrees it’s foundational. But assurances ring hollow against a proposed 40% NIH budget cut. ⁶ 6 This $47B to $27B figure needs a primary source for external citation. How does basic research thrive, let alone get protected, under such fiscal pressure? We need more than promises; we need a radical overhaul of funding that prioritizes actual discovery, not just a pledge not to actively decimate an already strained system. The question isn’t if we support basic science, but how, especially when the administration’s fiscal signals are so contradictory.

Simply “not gutting” it won’t cut it. The way basic science is funded and evaluated is itself a mess, rewarding safe, incremental steps over the “weird” but potentially revolutionary. Perverse incentives and the tyranny of metrics ⁷ 7 Citation counts, often used to measure impact, are a noisy proxy for actual influence, though some correlation exists. Teplitskiy et al. (2022) found only 18% of citations reflect major influence. infect basic science too. Maintaining its slice of a shrinking pie won’t fix these core issues. We need to reimagine how we identify and fund truly high-risk, high-reward basic science, moving beyond consensus-driven models.

Overhead Games: The IDC Shell Game

“It’s a ratchet that essentially makes it so that we concentrate the federal support for the money in the, to a select few universities.” – Director Bhattacharya ⁸ 8 00:27:04

The Director is right that the Indirect Cost (IDC) system fosters inequality. It’s often “bloated institutional machinery.” But the administration’s proposed flat 15% IDC cap, ⁹ 9 NIH Notice NOT-OD-25-068, Feb 7, 2025. This policy was blocked by court injunction, March 5, 2025. without nuanced consideration for diverse institutional needs, is a crude tool. It lacks data on how it will avoid crippling smaller institutions. Director Bhattacharya’s comparison to foundation IDCs ¹⁰ 10 Implied around 00:29:50 is also a bit of a feint; foundations operate with different capital and missions. They set rates knowing NIH IDCs cover broader costs. Instead of arbitrary caps, I want every NIH dollar, IDCs included, transparent and traceable to direct research support.

More importantly, fiddling with IDCs while slashing the overall NIH budget and workforce is a contradiction. If the goal is a healthier scientific ecosystem, this approach is self-defeating. Acknowledging IDC flaws is a tiny step; the real work is diversifying funding for direct research costs and ensuring adequate overall investment.

Openness Theater: Beyond Free PDFs

“…that publication ought to be available free to the public immediately upon publication… I made a decision, one of my first things I did was I said, why wait till December? Let’s just do it in July.” – Director Bhattacharya ¹¹ 11 00:34:42

Accelerating open access to publications is good. ¹² 12 This policy was officially moved up to July 1, 2025, as reported by Inside Higher Ed on May 2, 2025. Taxpayers shouldn’t pay twice. Huberman’s right, this should’ve happened ages ago ¹³ 13 00:37:49 . But if the public deserves access to taxpayer-funded products, then officials shaping science policy—Director Bhattacharya included—must share the evidence for their own assertions. Open papers are a start, but the spirit needs to be pervasive.

And what about the cost? U.S. research libraries, like those in the ARL, spend billions annually. ¹⁴ 14 ARL members spent $4.4 billion in 2023. Does this mandate mean higher Article Processing Charges (APCs), decreasing grant purchasing power and enriching journals? David Crotty estimates this could be a new ~$584 million annual burden. ¹⁵ 15 The Scholarly Kitchen, May 5, 2025. History here is bleak: Harold Varmus’s 1999 eBioMed proposal for a free NIH paper server was killed by publisher and society opposition. ¹⁶ 16 Michael Eisen, March 21, 2016; Richard Poynder, Nov 6, 2012. Early preprint adoption faced similar resistance. ¹⁷ 17 ASAPbio, Jan 19, 2017, responding to FASEB’s initial opposition. NIH formally allowed preprint citation in 2017 (SciELO in Perspective, May 17, 2017). Why not a federally maintained, independent repository for all data and manuscripts, finally breaking free from profit motives?

Nurturing Talent vs. Austerity

“…it’s early career scientists that are most likely to try out new ideas in their work, in their published work.” – Director Bhattacharya ¹⁸ 18 01:23:20

Director Bhattacharya says supporting Early-Career Researchers (ECRs) is a “major initiative,” ¹⁹ 19 Science Magazine, April 21, 2025. and that the current system is “too intolerant to failure” ²⁰ 20 01:33:29 . I agree. We must champion ECRs and intellectual risk-taking. But how, when the administration proposes a 40% NIH budget cut and workforce reductions? These actions will disproportionately crush young scientists, making the system more risk-averse. Specific plans for “direct, substantial, and early funding” for ECRs under such cuts are missing. It feels like an empty promise.

Prioritizing ECRs needs a broader overhaul. Dismantle the “cult of individualism” and “tyranny of metrics.” Reward sound design, rigorous work, tool development, data sharing, collaboration—not just individual accolades. And if you really want to incentivize risk, provide robust, stable funding. The current peer review system itself is problematic. Studies show it’s poor at predicting productivity ²¹ 21 Fang et al., eLife, 2016 and shows low inter-reviewer agreement. ²² 22 Pier et al., PNAS, 2018. It often defers to superficial metrics. For the “fundable but not top-scored” grants, the NIH should explore partial lottery systems, successfully used in New Zealand, ²³ 23 Barnett et al., Res Integr Peer Rev, 2021. Switzerland, Germany, the UK, and Austria. ²⁴ 24 URLs needed for SNSF, Volkswagen, British Academy, Austrian Science Fund reports. But lotteries are pointless if the budget is decimated. Huberman, for his part, seemed to accept the Director’s ECR support at face value, perhaps missing an opportunity to press on this glaring fiscal contradiction.

Truth & Consequences: The Replication Mess

“The published biomedical literature… most of the time that I’m reading papers in that literature, the papers I’m reading… is likely not true.” – Director Bhattacharya ²⁵ 25 01:49:18

Director Bhattacharya’s plan to fund replication work and establish a dedicated journal for it ²⁶ 26 Endocrine Society, April 2025; Science Magazine, April 21, 2025 acknowledges the “reproducibility crisis.” Funding replication is good. A separate journal? Less convinced. It risks ghettoizing these crucial studies. Success hinges on scale and commitment, both dubious under budget threats.

Restoring integrity needs more: FAIR data, open code, public post-publication peer review for all research. Why not require grant renewals (RPPRs) to include a plan for, or results of, a replication study by another group, with funds for this? Embed verification into research itself. That’s how you change culture.

DEI vs. Merit? A False Dichotomy

“The key thing is race essentialism. That what makes you you is your race, first and foremost.” – Director Bhattacharya ²⁷ 27 02:24:30 (His critique of DEI)

Director Bhattacharya says NIH will fund minority health research where race/sex are biologically relevant ²⁸ 28 02:22:53 , but critiques “DEI” and advocates for strictly merit-based funding. This has played out against mass grant terminations ²⁹ 29 Science Magazine, Feb 28, 2025 and an expedited appeals process. ³⁰ 30 Senate Appropriations Hearing, June 10, 2025.

His critique of “DEI” uses broad generalizations about “race essentialism” but lacks specific, data-driven examples of NIH diversity initiatives systemically promoting flawed science over merit. Without evidence, these claims feel political. Declaring the system “colorblind” ignores substantial evidence of systemic barriers. ³¹ 31 Studies show gender bias in Canadian funding (Tamblyn et al., CMAJ, 2018) and globally. URL needed for Schmaling & Gallo, PLoS One, 2023. True meritocracy requires a level playing field.

I’m concerned the focus on scrutinizing grants for “DEI” or “transgender” components creates a chilling effect on legitimate research into health disparities and sex/gender biology. The Director claims to want free intellectual thought ³² 32 03:33:34 , yet these actions drive self-censorship. Rigor should come from robust peer review, not politically charged keyword searches. Huberman could have pressed harder here on the potential for these policies to stifle the very open discourse Director Bhattacharya claims to champion.

Unspoken Levers: Real Structural Change

Beyond Director Bhattacharya’s points, critical structural reforms are missing. Cap PI funding: limit total NIH funds one PI can get annually. Huberman noted older labs taking “most of the pie” ³³ 33 01:24:44 . This frees resources for more investigators.

Reimagine senior scientist roles: create well-funded “emeritus investigator” or “wisdom-keeper” mechanisms. Retain their expertise without them monopolizing grants, letting the “next generation in” ³⁴ 34 01:27:49 , as Huberman said. Director Bhattacharya acknowledged young scientists serve older ones ³⁵ 35 01:25:18 but offered no structural fix.

And, crucially, resist destructive external “reforms.” The scientific community must fight politically motivated attacks. Director Bhattacharya’s own experiences with suppression ³⁶ 36 02:57:01, 02:58:01 should make him an ally, but his administration’s budget proposals are themselves a threat. ³⁷ 37 The “Bethesda Declaration” and $12B grant cancellations highlight this internal tension.

Coda: Beyond Empty Promises

Director Bhattacharya articulates some laudable goals for the NIH. Initiatives like the autism research platform ³⁸ 38 HHS Press Release, May 7, 2025. are steps. But these aspirations clash irreconcilably with proposed fiscal realities. The “golden age of science” is a comforting fiction. The enterprise has long been dysfunctional.

Genuine revitalization demands more than acknowledging problems. It needs courageous, data-driven dismantling of perverse incentives, radical funding diversification, unwavering commitment to openness, and robust investment in the next generation. The current rhetoric, set against austerity, risks being a smokescreen for managed decline. We must demand—and build—a scientific enterprise truly deserving of public trust and investment.